2 completed, 2 unknown. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Epimmune: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1 Safety and Immunogenicity Study of the Epitope Based DNA Vaccine (EP HIV-1090) in HIV-1 Infected Individuals Receiving Antiretroviral Therapy (ART) EP1090 - HIV Infections | Phase 1 | Unknown | Epimmune | 32 | 2006-10-01 | 2007-12-24 |
| Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer EP-2101, incomplete Freund's adjuvant - Lung Cancer | Phase 2 | Unknown | Epimmune | 2004-12-01 | 2013-11-06 | |
| An Open Label Study of a Peptide Vaccine in Patients With Stage III Colon Cancer EP2101 - Colonic Neoplasms, Colorectal Neoplasms | Phase 1 | Completed | Epimmune | 18 | 2003-02-01 | 2008-04-09 |
| An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung Cancer EP2101 - Carcinoma, Non-Small-Cell Lung, Lung Neoplasm | Phase 1 | Completed | Epimmune | 18 | 2003-01-01 | 2010-03-24 |
Carcinoma, Non-Small-Cell Lung (2) · Lung Neoplasms (2) · Neoplasms (2) · Acquired Immunodeficiency Syndrome (1) · Carcinoma, Large Cell (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · HIV Infections (1)
incomplete Freund's adjuvant (1)
United States (4)
Scott Plasman (1)